Non-myeloid Malignancy
📧 Sign up to get email alerts when something new happens for Non-myeloid Malignancy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-02-09Clinical Trial Update: Phase 3 Study to Evaluate the Safety and Efficacy of YPEG-rhG-CSF in Malignancies Receiving Chemotherapy [Phase 3]
A Phase 3 trial assessing the safety and efficacy of YPEG-rhG-CSF in non-myeloid malignancies receiving chemotherapy has completed.